http://purl.org/np/RA4BfLHxgKaBT9jlwRhO9ys9YgvTUELaz8TVVEGvUKsoo#Head
http://purl.org/np/RA4BfLHxgKaBT9jlwRhO9ys9YgvTUELaz8TVVEGvUKsoo
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RA4BfLHxgKaBT9jlwRhO9ys9YgvTUELaz8TVVEGvUKsoo#assertion
http://purl.org/np/RA4BfLHxgKaBT9jlwRhO9ys9YgvTUELaz8TVVEGvUKsoo
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RA4BfLHxgKaBT9jlwRhO9ys9YgvTUELaz8TVVEGvUKsoo#provenance
http://purl.org/np/RA4BfLHxgKaBT9jlwRhO9ys9YgvTUELaz8TVVEGvUKsoo
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RA4BfLHxgKaBT9jlwRhO9ys9YgvTUELaz8TVVEGvUKsoo#pubinfo
http://purl.org/np/RA4BfLHxgKaBT9jlwRhO9ys9YgvTUELaz8TVVEGvUKsoo
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RA4BfLHxgKaBT9jlwRhO9ys9YgvTUELaz8TVVEGvUKsoo#assertion
https://uts.nlm.nih.gov/uts/umls/concept/C0012634
http://wordnet-rdf.princeton.edu/lemma/modifying
https://uts.nlm.nih.gov/uts/umls/concept/C0242708
http://purl.org/np/RA4BfLHxgKaBT9jlwRhO9ys9YgvTUELaz8TVVEGvUKsoo#provenance
http://purl.org/np/RA4BfLHxgKaBT9jlwRhO9ys9YgvTUELaz8TVVEGvUKsoo#_assertion
http://www.w3.org/ns/prov#wasGeneratedBy
S&T TWOC Project - version 4
http://purl.org/np/RA4BfLHxgKaBT9jlwRhO9ys9YgvTUELaz8TVVEGvUKsoo#_assertion
http://www.w3.org/ns/prov#wasGeneratedBy
S&T TWOC version 3
http://purl.org/np/RA4BfLHxgKaBT9jlwRhO9ys9YgvTUELaz8TVVEGvUKsoo#_version
http://www.w3.org/ns/prov#value
2
http://purl.org/np/RA4BfLHxgKaBT9jlwRhO9ys9YgvTUELaz8TVVEGvUKsoo#assertion
http://www.w3.org/ns/prov#generatedAtTime
2023-07-20T09:47:08.417366
http://purl.org/np/RA4BfLHxgKaBT9jlwRhO9ys9YgvTUELaz8TVVEGvUKsoo#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0003-4692-1377
http://purl.org/np/RA4BfLHxgKaBT9jlwRhO9ys9YgvTUELaz8TVVEGvUKsoo#assertion
http://www.w3.org/ns/prov#wasDerivedFrom
https://doi.org/10.1007/s10067-021-05743-2
http://www.w3.org/1999/02/22-rdf-syntax-ns#OBJECT
http://www.w3.org/2000/01/rdf-schema#label
anti-rheumatic drugs ( DMARDs )
http://www.w3.org/1999/02/22-rdf-syntax-ns#OBJECT-POSITION
http://www.w3.org/2000/01/rdf-schema#label
(106, 113)
http://www.w3.org/1999/02/22-rdf-syntax-ns#PREDICATE
http://www.w3.org/2000/01/rdf-schema#label
modifying
http://www.w3.org/1999/02/22-rdf-syntax-ns#PREDICATE-POSITION
http://www.w3.org/2000/01/rdf-schema#label
114, 123
http://www.w3.org/1999/02/22-rdf-syntax-ns#SUBJECT
http://www.w3.org/2000/01/rdf-schema#label
disease
http://www.w3.org/1999/02/22-rdf-syntax-ns#SUBJECT-POSITION
http://www.w3.org/2000/01/rdf-schema#label
(106, 113)
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://www.w3.org/2000/01/rdf-schema#label
There is a paucity of high-quality evidence to guide The pharmacotherapy of Takayasu arteritis (TAK) with disease-modifying anti-rheumatic drugs (DMARDs).
http://www.w3.org/2000/01/rdf-schema#ABSTRACT-UID
http://localhost:8555/solr/triples/select?fl=TRIPLE_UID,%20CORD_UID,%20SUBJECT,%20PREDICATE,%20WORDNET_SEMREL,%20%20OBJECT,%20PRED_POSITION,%20SUBJECT_CUIS,%20OBJECT_CUIS,%20UMLS_SEMREL,%20PRED_POSITION,%20PREDICATE-LEMMA&q=CORD_UID:fcy3fn4c&rows=50
fcy3fn4c
http://www.w3.org/2000/01/rdf-schema#TRIPLE-UID
http://localhost:8555/solr/triplesselect?q=TRIPLE_UID:fcy3fn4c-TRIPLE-ABSTRACT-8
fcy3fn4c-TRIPLE-ABSTRACT-8
https://uts.nlm.nih.gov/uts/umls/concept/C0012634
http://www.w3.org/2000/01/rdf-schema#label
disease
https://uts.nlm.nih.gov/uts/umls/concept/C0242708
http://www.w3.org/2000/01/rdf-schema#label
dmards
http://purl.org/np/RA4BfLHxgKaBT9jlwRhO9ys9YgvTUELaz8TVVEGvUKsoo#pubinfo
http://purl.org/np/RA4BfLHxgKaBT9jlwRhO9ys9YgvTUELaz8TVVEGvUKsoo#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RA4BfLHxgKaBT9jlwRhO9ys9YgvTUELaz8TVVEGvUKsoo#sig
http://purl.org/nanopub/x/hasPublicKey
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
http://purl.org/np/RA4BfLHxgKaBT9jlwRhO9ys9YgvTUELaz8TVVEGvUKsoo#sig
http://purl.org/nanopub/x/hasSignature
Mvo/czpA70q41UlMOOm1cwrW6ICpGdksuh5oH4VqdXF+pHH8K4mbrzv7AqgmfcW2/hooJVWH54Y2LM0nUoqmlua/ycbaAJ9Mi4+zbHr5eZ914StH1QQogJfWy2OiSPMPGkApeup9cdqj4GmeGhrtQmOz+EQ8OwjWoDmGLgJlafarKqlPUgedwwLj+JzYcluyc3WvKC5oDfM3xotMuZ5BLeQOd7f5Tc9NmR3ri0PgPVEcaWJPal5MI9yabV8W2fMAljBY3RxE5TVVbwhbOgNJ/2l0SmGgTMdkUJfnKFp8ZHakf6dmxlYyAOnMpKNuDeMYK9QcQAIaF9DRQujtNwl5Bji53eIE2+UUe+9TX3/iSRuSlGpd40xGapR6jlzAvceNINZ4sxg/Lz39nO1OP2YkKSW4pKOp/rNXEouQsqrqaM2YOemmoFWh8aR/brptQAa9Uuf6ws5VBGyVfpyMrweIUKkxoR1oezDEBqqtaQyEI2QbgFt/7OR7j7RT7RtODEdz
http://purl.org/np/RA4BfLHxgKaBT9jlwRhO9ys9YgvTUELaz8TVVEGvUKsoo#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RA4BfLHxgKaBT9jlwRhO9ys9YgvTUELaz8TVVEGvUKsoo
http://purl.org/np/RA4BfLHxgKaBT9jlwRhO9ys9YgvTUELaz8TVVEGvUKsoo
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0003-4692-1377